Nymax™ REC Recycled Nylon Formulations Complēt™ Moisture Resistant Nylons

Nymax™ REC Recycled Nylon Formulations Complēt™ Moisture Resistant Nylons

Nymax™ REC Recycled Nylon Formulations Complēt™ Moisture Resistant Nylons

VERSAFLEX™ PF Camada de aderência para para películas protetoras de superfície BOLETIM TÉCNICO Propriedades Versaflex PF MD6727 Versaflex PF DM6741 Versaflex PF DM6649 Versaflex PF 9512 Versaflex PF MD6666 Versaflex PF DM6748 Versaflex PF DM6700 Características Baixa aderência Baixa aderência; usado para personalizar aderência com MD6700 Aderência de baixa a média Oferta de valor Aderência média Gel/resíduos baixos Estrutura de baixa aderência Alta aderência Resistência a descolamento Baixa Baixa a média Média Média a alta Média a alta Alta Alta Aplicações Películas ópticas Eletrodomésticos Plásticos Construção/metais expostos Metais acabados Aço/metais pintados Metais expostos MFR a 190 °C/2,16 kg -- 4,5 17 5,4 21 4,8 6,5 MFR a 230 °C/2,16 kg 10 20 -- -- -- -- -- Gravidade específica, g/cc 0,92 0,91 0,92 0,92 0,94 0,94 0,94 Dureza, Shore A 50 49 37 38 37 31 30 G' a 23°C, Pa 28,0 x 105 10,4 x 106 8,3 x 105 -- 9,9 x 105 11,8 x 105 10,0 x 105 DMA Tg, °C -29 -30 -9 10 11 15 21 Película LDPE/Versaflex PF1 Descolamento de 180°, N/25 mm Aço inoxidável após 20 min a 25 °C 0,5 2,2 3,2 6,1 6,7 8,5 8,6 após 7 dias a 25°C 0,6 2,7 4,3 5,5 8,2 8,3 10,3 PMMA2 após 20 min a 25 °C 1,1 1,7 3,8 4,9 6,9 8,3 8,8 após 20 min a 75 °C 2,8 4,1 5,1 6,9 9,0 10,7 11,8 após 7 dias a 75°C 4,0 4,4 5,9 9,8 8,4 9,8 10,3 Policarbonato3 após 20 min a 25 °C 1,4 2,2 3,8 6,8 6,3 8,4 7,0 após 20 min a 75 °C 3,4 4,8 6,7 8,8 8,8 10,0 11,8 após 7 dias a 75°C 4,6 6,5 7,5 10,6 11,6 10,6 13,8 1 Espessura da película: LDPE 51 mícrons/Versaflex PF 25 mícrons 2 Arkema Plexiglas™ V052-100 (Plexiglas é uma marca comercial da Arkema France Corp). 3 Sabic Lexan™ L52-111 (Lexan é uma marca comercial da Sabic Innovative Plastics) PROPRIEDADES FÍSICAS DE FORMULAÇÕES DE CAMADA DE ADERÊNCIA VERSAFLEX PF SELECIONADAS DESCRIÇÃO DO PRODUTO As formulações Versaflex™ PF são especialmente desenvolvidas para a fabricação de películas protetoras de superfície coextrudadas de fácil aplicação, mantêm a aderência com espessura mínima, descolam suavemente e são removidas completamente, sem nenhum ou com pouco resíduo.

TECHNICAL BULLETIN VERSAFLEX™ PF Tack Layer for Surface Protective Films Properties Versaflex PF MD6727 Versaflex PF MD6741 Versaflex PF MD6649 Versaflex PF 9512 Versaflex PF MD6666 Versaflex PF MD6748 Versaflex PF MD6700 Features Low Tack Low Tack; Used for tailoring tack with MD6700 Low-Medium Tack Value Offering Medium Tack Low Gel/Residuals Low Tack Build High Tack Peel Strength Low Low-Medium Medium Medium-High Medium-High High High Applications Optical Films Home Appliances Plastics Construction/Bare Metals Finished Metals Steel/Painted Metals Bare Metals MFR @ 190°C/2.16 kg -- 4.5 17 5.4 21 4.8 6.5 MFR @ 230°C/2.16 kg 10 20 -- -- -- -- -- Specific Gravity, g/cc 0.92 0.91 0.92 0.92 0.94 0.94 0.94 Hardness, Shore A 50 49 37 38 37 31 30 G' @ 23°C, Pa 28.0 x 105 10.4 x 106 8.3 x 105 -- 9.9 x 105 11.8 x 105 10.0 x 105 DMA Tg, °C -29 -30 -9 10 11 15 21 LDPE/Versaflex PF Film1 180° Peel, N/25mm Stainless Steel after 20 min @ 25°C 0.5 2.2 3.2 6.1 6.7 8.5 8.6 after 7 days @ 25°C 0.6 2.7 4.3 5.5 8.2 8.3 10.3 PMMA2 after 20 min @ 25°C 1.1 1.7 3.8 4.9 6.9 8.3 8.8 after 20 min @ 75°C 2.8 4.1 5.1 6.9 9.0 10.7 11.8 after 7 days @ 75°C 4.0 4.4 5.9 9.8 8.4 9.8 10.3 Polycarbonate3 after 20 min @ 25°C 1.4 2.2 3.8 6.8 6.3 8.4 7.0 after 20 min @ 75°C 3.4 4.8 6.7 8.8 8.8 10.0 11.8 after 7 days @ 75°C 4.6 6.5 7.5 10.6 11.6 10.6 13.8 1 Film thickness: 51 micron LDPE/25 micron Versaflex PF 2 Arkema Plexiglas™ V052-100 (Plexiglas is a trademark of Arkema France Corp.) 3 Sabic Lexan™ L52-111 (Lexan is a trademark of Sabic Innovative Plastics) PHYSICAL PROPERTIES OF SELECTED VERSAFLEX PF TACK LAYER FORMULATIONS PRODUCT DESCRIPTION Versaflex™ PF formulations are specially developed for the manufacture of co-extruded surface protective films that apply easily, maintain tack with minimal build, peel smoothly and remove completely with little-to-no residue or ghosting.

KEY CHARACTERISTICS • UL 94 V-2, V-0, 5VA ratings and elevated RTI ratings • GWFI (IEC 60695-11-10) up to 960°C • Comparative Tracking Index (CTI) PLC 0, 600V ratings • Injection molding and extrusion grades • Non-halogen grades available • Low dielectric performance with selected formulations • Good recyclability • Colorable MARKETS & APPLICATIONS Applications that require flame retardant performance including: • Transportation: Interior components, seat components, door panels, aircraft interiors, railway interiors, boat interiors • Construction & Building Materials: Cable insulation, pipes and fittings, insulation materials • Consumer – Appliance casings, housings, covers, fume hoods, battery packages, furniture • Industrial Equipment: Machine housings • Energy, Electrical & Electronic, E-Mobility: Battery frames, electrical housings, connectors • Telecommunication: Cable management • Packaging: Transportation of sensitive goods • Healthcare: Medical device housings and components PRODUCT BULLETIN MAXXAM FR FLAME RETARDANT POLYOLEFIN FORMULATIONS Non-halogenated Halogenated PP Homopolymer Copolymer Homopolymer Copolymer Unit Unfilled Glass Fiber Mineral Unfilled Glass Fiber Mineral Unfilled Glass Fiber Mineral Unfilled Glass Fiber Mineral Characteristic Talcum Talcum Talcum Talcum Reinforcement Mass-% 0 5–30 5–30 0 20–30 5-20 0 5–30 5–20 0 5–30 5–20 Colorable – ++ ++ + ++ ++ + + + + + + + Density g/cm3 0,9–1,08 1,28–1,37 0,98–1,55 0,92–1,06 1,25–1,35 0,95–1,28 0,94–1,04 1,3–1,55 1,01–1,42 0,96–1,01 0,94–1,58 0,95–1,46 Tensile Strength MPa 25–30 30–70 25–35 16–22 40–65 15–25 25-–35 30–70 25–35 20–24 20–55 -25 E-Modulus (Tensile) MPa 1600–2500 2500–8200 2500–4000 800–1200 2000–8000 1600–3000 1300–2000 3000–8900 1900–3500 1000–1400 1200–7500 1500–3000 Izod Impact 23°C notched % 2,0–4,5 3,5–7,5 2,5–4,5 5–40 2,5–18 2,5–6 2,5–4,5 3,5–6,0 3,0–7,0 4,0–40 2,5–16 2,5–10 Max.

Microsoft Word - Avient Announces Fourth Quarter and Full Year 2024 Results 1 NEWS RELEASE FOR IMMEDIATE RELEASE Avient Announces Fourth Quarter and Full Year 2024 Results • Fourth quarter sales increased 4% to $747 million and full year sales increased 3% to $3,240 million • Organic sales, which excludes the impact of foreign exchange, grew 5% and 4% in the fourth quarter and full year, respectively, driven by positive growth in all regions • Fourth quarter and full year GAAP EPS from continuing operations of $0.52 and $1.84 compared to $0.30 and $0.83 in the prior year • Fourth quarter adjusted EPS of $0.49, above mid-point of guidance range of $0.46 to $0.50 and includes a $0.01 unfavorable impact from foreign exchange • 2024 full year adjusted EPS of $2.66 represents an increase of 13% over the prior year, driven by sales growth and margin expansion in both segments • 2025 full year adjusted EPS expected to range from $2.70 to $2.94; the mid-point represents 11% growth when excluding the unfavorable impact of foreign exchange of $0.12 CLEVELAND – February 13, 2025 – Avient Corporation (NYSE: AVNT), an innovator of materials solutions, today announced its fourth quarter and full year results for 2024. The mid-point of the adjusted EPS range of $2.82 represents 11% growth, excluding the unfavorable impact from foreign exchange of $0.12 for the full year.” Three Months Ended December 31, 2024 2023 Reconciliation to Condensed Consolidated Statements of Income $ EPS(1) $ EPS(1) Net income from continuing operations attributable to Avient shareholders $ 48.3 $ 0.52 $ 27.8 $ 0.30 Special items, after-tax (Attachment 3) (18.0) (0.20) 5.4 0.06 Amortization expense, after-tax 14.8 0.17 15.0 0.16 Adjusted net income / EPS $ 45.1 $ 0.49 $ 48.2 $ 0.52 (1) Per share amounts may not recalculate from figures presented herein due to rounding Year Ended December 31, 2024 2023 Reconciliation to Condensed Consolidated Statements of Income $ EPS(1) $ EPS(1) Net income from continuing operations attributable to Avient shareholders $ 169.5 $ 1.84 $ 75.8 $ 0.83 Special items, after-tax (Attachment 3) 15.9 0.17 79.3 0.86 Amortization expense, after-tax 59.5 0.65 61.5 0.67 Adjusted net income / EPS $ 244.9 $ 2.66 $ 216.6 $ 2.36 (1) Per share amounts may not recalculate from figures presented herein due to rounding 8 Attachment 2 Avient Corporation Condensed Consolidated Statements of Income (Unaudited) (In millions, except per share data) Three Months Ended December 31, Year Ended December 31, 2024 2023 2024 2023 Sales $ 746.5 $ 719.0 $ 3,240.4 $ 3,142.8 Cost of sales 487.0 510.1 2,183.7 2,250.3 Gross margin 259.5 208.9 1,056.7 892.5 Selling and administrative expense 173.9 165.8 727.4 695.7 Operating income 85.6 43.1 329.3 196.8 Interest expense, net (25.5) (26.8) (105.6) (115.3) Other income, net 3.2 4.3 1.1 5.8 Income from continuing operations before income taxes 63.3 20.6 224.8 87.3 Income tax (expense) benefit (14.8) 7.0 (54.1) (11.0) Net income from continuing operations 48.5 27.6 170.7 76.3 Income (loss) from discontinued operations, net of income taxes — 0.8 — (0.1) Net income 48.5 28.4 170.7 76.2 Net (income) loss attributable to noncontrolling interests (0.2) 0.2 (1.2) (0.5) Net income attributable to Avient common shareholders $ 48.3 $ 28.6 $ 169.5 $ 75.7 Earnings per share attributable to Avient common shareholders - Basic: Continuing operations $ 0.53 $ 0.30 $ 1.86 $ 0.83 Discontinued operations — 0.01 — — Total $ 0.53 $ 0.31 $ 1.86 $ 0.83 Earnings per share attributable to Avient common shareholders - Diluted: Continuing operations $ 0.52 $ 0.30 $ 1.84 $ 0.83 Discontinued operations — 0.01 — — Total $ 0.52 $ 0.31 $ 1.84 $ 0.83 Cash dividends declared per share of common stock $ 0.2700 $ 0.2575 $ 1.0425 $ 1.0000 Weighted-average shares used to compute earnings per common share: Basic 91.4 91.2 91.3 91.1 Diluted 92.2 91.9 92.0 91.8 9 Attachment 3 Avient Corporation Summary of Special Items (Unaudited) (In millions, except per share data) Special items (1) Three Months Ended December 31, Year Ended December 31, 2024 2023 2024 2023 Cost of sales: Restructuring costs, including accelerated depreciation $ (4.6) $ (2.0) $ 1.0 $ (11.9) Environmental remediation costs (6.8) (17.2) (35.0) (69.7) Reimbursement of previously incurred environmental costs 34.7 1.6 34.7 1.6 Impact on cost of sales 23.3 (17.6) 0.7 (80.0) Selling and administrative expense: Restructuring and employee separation costs (2.6) (1.1) (9.2) (14.9) Legal and other (0.3) (6.1) (10.4) (15.2) Acquisition related costs — (1.3) (2.5) (5.9) Impact on selling and administrative expense (2.9) (8.5) (22.1) (36.0) Impact on operating income 20.4 (26.1) (21.4) (116.0) Interest expense, net - financing costs — (0.1) (2.3) (2.3) Pension and post retirement mark-to-market adjustments and other 3.5 3.8 3.6 3.7 Impact on other income, net 3.5 3.8 3.6 3.7 Impact on income from continuing operations before income taxes 23.9 (22.4) (20.1) (114.6) Income tax (expense) benefit on above special items (5.8) 4.5 6.1 27.7 Tax adjustments(2) (0.1) 12.5 (1.9) 7.6 Impact of special items on net income from continuing operations $ 18.0 $ (5.4) $ (15.9) $ (79.3) Diluted earnings per common share impact $ 0.20 $ (0.06) $ (0.17) $ (0.86) Weighted average shares used to compute adjusted earnings per share: Diluted 92.2 91.9 92.0 91.8 (1) Special items include charges related to specific strategic initiatives or financial restructuring such as: consolidation of operations; debt extinguishment costs; costs incurred directly in relation to acquisitions or divestitures; employee separation costs resulting from personnel reduction programs, plant realignment costs, executive separation agreements; asset impairments; settlement gains or losses and mark-to- market adjustments associated with gains and losses on pension and other post-retirement benefit plans; environmental remediation costs, fines, penalties and related insurance recoveries related to facilities no longer owned or closed in prior years; gains and losses on facility or property sales or disposals; results of litigation, fines or penalties, where such litigation (or action relating to the fines or penalties) arose prior to the commencement of the performance period; one-time, non-recurring items; and the effect of changes in accounting principles or other such laws or provisions affecting reported results. (2) Tax adjustments include the net tax impact from non-recurring income tax items and certain adjustments to uncertain tax position reserves and valuation allowances. 10 Attachment 4 Avient Corporation Condensed Consolidated Balance Sheets (Unaudited) (In millions) Year Ended December 31, 2024 2023 ASSETS Current assets: Cash and cash equivalents $ 544.5 $ 545.8 Accounts receivable, net 399.5 399.9 Inventories, net 346.8 347.0 Other current assets 131.3 114.9 Total current assets 1,422.1 1,407.6 Property, net 955.3 1,028.9 Goodwill 1,659.7 1,719.3 Intangible assets, net 1,450.4 1,590.8 Operating lease assets, net 89.1 65.3 Deferred income tax assets 81.3 92.3 Other non-current assets 153.2 64.3 Total assets $ 5,811.1 $ 5,968.5 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Short-term and current portion of long-term debt $ 7.7 $ 9.5 Accounts payable 417.4 432.3 Accrued expenses and other current liabilities 331.0 331.8 Total current liabilities 756.1 773.6 Non-current liabilities: Long-term debt 2,059.3 2,070.5 Deferred income taxes 260.4 281.6 Other non-current liabilities 405.7 504.8 Total non-current liabilities 2,725.4 2,856.9 SHAREHOLDERS' EQUITY Avient shareholders’ equity 2,313.8 2,319.2 Noncontrolling interest 15.8 18.8 Total equity 2,329.6 2,338.0 Total liabilities and equity $ 5,811.1 $ 5,968.5 11 Attachment 5 Avient Corporation Condensed Consolidated Statements of Cash Flows (Unaudited) (In millions) Year Ended December 31, 2024 2023 Operating activities Net income $ 170.7 $ 76.2 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization 179.7 188.8 Increase in environmental insurance receivable (34.0) — Deferred income tax benefit (23.8) (61.3) Share-based compensation expense 15.4 13.2 Changes in assets and liabilities, net of the effect of acquisitions: (Increase) decrease in accounts receivable (15.2) 38.6 (Increase) decrease in inventories (13.7) 24.3 Increase (decrease) in accounts payable 0.3 (22.2) Decrease in pension, retirement benefits and deferred compensation (34.3) (8.7) Taxes paid on gain on sale of business — (104.1) (Decrease) increase in environmental obligations (11.2) 38.9 Accrued expenses and other assets and liabilities, net 22.9 17.9 Net cash provided by operating activities 256.8 201.6 Investing activities Capital expenditures (121.9) (119.4) Net proceeds from divestiture — 7.3 Proceeds from plant closures 3.4 7.6 Other investing activities (2.1) 10.3 Net cash used by investing activities (120.6) (94.2) Financing activities Proceeds from long-term borrowings 650.0 — Payments on long-term borrowings (660.9) (105.8) Cash dividends paid (94.0) (90.2) Payments on withholding tax on share awards (6.4) (3.4) Debt financing costs (9.6) (2.3) Net cash used by financing activities (120.9) (201.7) Effect of exchange rate changes on cash (16.6) (1.0) Decrease in cash and cash equivalents (1.3) (95.3) Cash and cash equivalents at beginning of year 545.8 641.1 Cash and cash equivalents at end of year $ 544.5 $ 545.8 12 Attachment 6 Avient Corporation Business Segment Operations (Unaudited) (In millions) Operating income and earnings before interest, taxes, depreciation and amortization (EBITDA) at the segment level does not include: special items as defined in Attachment 3; corporate general and administration costs that are not allocated to segments; intersegment sales and profit eliminations; share-based compensation costs; and certain other items that are not included in the measure of segment profit and loss that is reported to and reviewed by the chief operating decision maker.

Devant Peter Van MELKEBEKE, notaire à Bruxelles (premier canton), exerçant sa fonction dans la société " Berquin Notaires ", ayant son siège à Bruxelles, avenue Lloyd George 11, S'EST REUNIE L'assemblée générale extraordinaire de la société anonyme " CLARIANT PLASTICS & COATINGS (BELGIUM) SA ", ayant son siège à 1348 Ottignies-Louvain-la-Neuve, Fond Jean Pâques 1, ci-après dénommée la " Société ". (...) La société a pour objet, en Belgique ou à l'étranger, pour compte propre ou pour compte de tiers ou en participation avec des tiers : L'exploitation et le négoce dans le sens le plus large, notamment l'importation, l'exportation, l'achat, la fabrication, la modification, le façonnage, l'emballage, la représentation, la vente et le commerce de produits chimiques : colorants, auxiliaires, pigments, mélanges-maître et additifs pour les matières textiles et plastiques, le cuir, le papier, l'aluminium, les laques, peintures et encres d'imprimerie, de produits provenant d'industries connexes ainsi que de tous services et tout matériel pouvant se rapporter aux domaines susmentionnés. *20358298* Déposé 30-11-2020 Bi jla ge n bi j h et B el gi sc h St aa ts bl ad - 02 /1 2/ 20 20 - An ne xe s du M on ite ur b el ge - suiteVolet B Au verso : Nom et signature (pas applicable aux actes de type "Mention"). ayant pouvoir de représenter la personne morale à l'égard des tiers Mentionner sur la dernière page du Volet B : Au recto : Nom et qualité du notaire instrumentant ou de la personne ou des personnes Moniteur belge Réservé au Mod PDF 19.01 La société peut accomplir toutes opérations généralement quelconques, commerciales, industrielles, financières, mobilières ou immobilières, se rapportant directement ou indirectement à son objet. Article 11.

WE’VE GOT YOU COVERED. http://www.art.canaco.org https://www.avient.com/sites/default/files/2020-11/gls-acqua-plose-case-study.pdf 1http://store.elsevier.com/Handbook-of-Polymer-Applications-in-Medicine- and-Medical-Devices/isbn-9780323221696/ Tear Resistance PERFORMANCE COMPARISON In Handbook of Polymer Applications in Medicine and Medical Devices,1 Laurence W. Learn more http://www.avient.com/tpeknowledgecenter http://www.avient.com Next Page 2: Previous Page 2: Next Page 3: Previous Page 3: Next Page 4: Previous Page 4: Next Page 8: Previous Page 8: Next Page 5: Previous Page 5: Next Page 9: Previous Page 9: Next Page 6: Previous Page 6: Previous Page 10: Next Page 10: Next Page 7: Previous Page 7: Next Page 11: Previous Page 11: Next Page 12: Previous Page 12: Next Page 13: Previous Page 13: Next Page 32: Previous Page 33: Next Page 34: Previous Page 37: Next Page 14: Previous Page 14: Next Page 15: Previous Page 16: Next Page 16: Previous Page 17: Next Page 17: Previous Page 18: Next Page 33: Previous Page 34: Next Page 18: Previous Page 19: Next Page 19: Previous Page 20: Next Page 20: Previous Page 21: Next Page 21: Previous Page 22: Next Page 22: Previous Page 23: Next Page 23: Previous Page 24: Next Page 24: Previous Page 25: Next Page 25: Previous Page 26: Next Page 26: Previous Page 27: Next Page 27: Previous Page 28: Next Page 28: Previous Page 29: Next Page 29: Previous Page 30: Next Page 30: Previous Page 31: Next Page 31: Previous Page 32: Previous Page 15: Previous Page 35: Previous Page 36:

NOTICE OF 2020 ANNUAL MEETING OF SHAREHOLDERS AND PROXY STATEMENT PolyOne Corporation PROPOSAL 1 — ELECTION OF BOARD OF DIRECTORS ............................................................................................................ 11 PROPOSAL 2 — ADVISORY VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION ............................ 16 PROPOSAL 3 — APPROVAL OF THE POLYONE CORPORATION 2020 EQUITY AND INCENTIVE COMPENSATION PLAN .........................................................................................................................................17 PROPOSAL 4 — RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ................................................................................................................................................30 MESSAGE FROM OUR CEO www.virtualshareholdermeeting.com/POL2020 Your vote is very important. Other Awards (a) Section 3 Section 10 (b) Section 10 (c) (d) Section 10 Section 10 (e) Section 10 (f) Section 10 11. a) Section 12 (b) Section 12 Section 17(b) ( ) Section 12 Section 17(b)( ) (c) Section 10 Section 11(b) ( ) (d) Section 17(b) ( ) Section 12 18.